Clinical Trial

Parent Education About Human Papillomavirus (HPV)

Completed
View on ClinicalTrials.gov →
Summary
Human papillomavirus (HPV) vaccination is an effective strategy for preventing HPV-related diseases; however, parental knowledge and vaccination intention may influence vaccine uptake among children and adolescents. This randomized controlled trial evaluated the effect of a Health Belief Model (HBM)-based parent education intervention on HPV knowledge and HPV vaccination intention among parents of children aged 9-14 years. A total of 64 parents were enrolled and randomly assigned to an intervention group (n=32) or a control group (n=32). Following baseline assessment, the intervention group received a single, approximately 40-minute, face-to-face, nurse-led educational session based on the constructs of the Health Belief Model. The control group received no educational intervention during the five-week comparison period. HPV knowledge and vaccination intention were assessed at baseline and five weeks later. After completion of the five-week assessment, the control group received the same educational session for ethical reasons.
Protocol Amendment History 5 changes
critical Trial completed 2026-08-11
critical Primary endpoint(s) modified 2026-08-11
notable Enrollment increased: 52 -> 64 participants 2026-08-11
notable Primary completion moved earlier: 2026-06-15 -> 2026-03-31 2026-08-11
minor Completion moved earlier: 2026-12-15 -> 2026-03-31 2026-08-11
Trial Details
NCT Number NCT07447245
Lead Sponsor KTO Karatay University
Conditions HPV (Human Papillomavirus)-Associated
Enrollment 64 participants
Start Date 2026-02-25
Primary Completion 2026-03-31 (estimated)
Study Completion 2026-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-10